- Home
- CFSB vs CNTB Comparison
CFSB vs CNTB Comparison
Compare CFSB & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFSB
- CNTB
- Stock Information
- Founded
- CFSB 1889
- CNTB 2012
- Country
- CFSB United States
- CNTB United States
- Employees
- CFSB N/A
- CNTB N/A
- Industry
- CFSB Major Banks
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- CFSB Finance
- CNTB Health Care
- Exchange
- CFSB Nasdaq
- CNTB Nasdaq
- Market Cap
- CFSB 51.6M
- CNTB 43.2M
- IPO Year
- CFSB N/A
- CNTB 2021
- Fundamental
- Price
- CFSB $7.94
- CNTB $0.76
- Analyst Decision
- CFSB
- CNTB Strong Buy
- Analyst Count
- CFSB 0
- CNTB 1
- Target Price
- CFSB N/A
- CNTB $8.00
- AVG Volume (30 Days)
- CFSB 1.3K
- CNTB 212.7K
- Earning Date
- CFSB 04-29-2025
- CNTB 03-31-2025
- Dividend Yield
- CFSB N/A
- CNTB N/A
- EPS Growth
- CFSB N/A
- CNTB N/A
- EPS
- CFSB N/A
- CNTB N/A
- Revenue
- CFSB $7,484,000.00
- CNTB $26,033,000.00
- Revenue This Year
- CFSB N/A
- CNTB N/A
- Revenue Next Year
- CFSB N/A
- CNTB N/A
- P/E Ratio
- CFSB N/A
- CNTB N/A
- Revenue Growth
- CFSB N/A
- CNTB N/A
- 52 Week Low
- CFSB $6.34
- CNTB $0.51
- 52 Week High
- CFSB $8.28
- CNTB $2.08
- Technical
- Relative Strength Index (RSI)
- CFSB 53.90
- CNTB 48.36
- Support Level
- CFSB $7.85
- CNTB $0.78
- Resistance Level
- CFSB $8.05
- CNTB $0.85
- Average True Range (ATR)
- CFSB 0.07
- CNTB 0.06
- MACD
- CFSB -0.01
- CNTB 0.00
- Stochastic Oscillator
- CFSB 35.84
- CNTB 46.06
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.